Podcasts about integrated research

Send us a textHave you ever noticed the gap between where your organization is and where it needs to be widening every day—especially when workflows are undefined or changing?In this episode of Lean by Design, we sit down with Liam O'Neill of BPM‑D to tackle the big question: do you invest in building process capabilities internally or lean on outside consultants? We'll walk you through evaluating your readiness, embedding process ownership in leadership, and starting with a real business challenge so you can create sustainable, scalable process excellence rather than just putting out fires. Learn more about BPMD at https://bpm-d.com/Connect with Liam at https://www.linkedin.com/in/l-oneill/Ready to assess your organization's efficiency? Connect with us at leanbydesign@sigmalabconsulting.com to uncover high-impact improvement opportunities.

During EMS Week, it's important to recognize dedicated EMS providers as well as spotlight ways they can move forward in their careers. To that end, the fire and EMS degree programs offered by Columbia Southern University were designed with busy professionals in mind. Keith Padgett, MS, EFO, a 45-year veteran of the fire service, serves as academic program director for the fire and emergency medical services programs at CSU. In our latest EMS World podcast, host Mike McCabe sits down with Padgett to learn more about the career-expanding options available to today's hardworking first responders. Sponsored by Columbia Southern University. Follow EMS World on social media at EMSWorldOFCL

Send us a textHave you ever watched a rowing team give it their all only to spin in circles? That's exactly how we feel when our teams pour in effort without clear roles and responsibilities.In this episode of Lean by Design, we explore how vague decision‐making and overlapping tasks quietly drain momentum, leading to missed deadlines and frustrated teams. We'll share how defining ownership, fostering psychological safety, and using simple digital tools can align everyone's efforts so your boat actually moves forward.Join us to learn how clarity of roles can transform your team's productivity and make the journey more rewarding for everyone.Ready to assess your organization's efficiency? Connect with us at leanbydesign@sigmalabconsulting.com to uncover high-impact improvement opportunities.

Send us a textIn this episode, we explore how small, intentional improvements—not sweeping changes—drive real progress in biopharma operations. The discussion highlights a common challenge: the disconnect between strategy and execution, often due to underutilized middle management.You'll learn a simple framework for creating meaningful change: start within your sphere of influence, map key inputs and outputs, and implement solutions that reduce effort while increasing visibility. Small wins in project management can build momentum, leading to better accountability, decision-making, and resource allocation.The conversation also covers the importance of tools and training—many organizations have powerful software but lack the support to maximize its potential. The takeaway? Improve your own workflows first to build credibility before driving broader change.Ready to assess your organization's efficiency? Connect with us at leanbydesign@sigmalabconsulting.com to uncover high-impact improvement opportunities.

While the 40th Space Symposium's theme was “Building Partnerships to Secure our Future”, everyone in Colorado Springs, Colorado was talking about building President Trump's Next Generation Missile Defense Shield, a.k.a.: “Golden Dome For America.” This week's guest cautions us that you cannot have a space-based missile defense shield without the ground segment. Laura Winter speaks with Mark Henrie, Divisional Vice President, Amentum Missile Defense Group, and Deputy Program Manager, Integrated Research & Development Enterprise Solution.

Join Fred Burton as he interviews Niall Herlehy, Visa's lead for Protective Intelligence, about building world-class Global Security Operations Centers (GSOCs). Learn how forward-thinking companies like Visa are addressing complex threats and protecting their teams in an unpredictable world. This episode dives into practical advice and actionable strategies for professionals building or optimizing their security programs.You'll learn:How GSOCs have evolved to meet modern security challengesBest practices for managing critical intelligence and stakeholder relationshipsTips for starting and scaling GSOCs using benchmarking and collaborationLearn more about Ontic's Integrated Research.

When companies investigate incidents and address threats posed to the business and its people, the aftermath of resolution is frequently overlooked. Recognizing this gap, Wendy Bailey established Capital One's Care Team. Comprising of internal members, this team extends support to individuals who have suffered injuries or witnessed threat activity, supporting a comprehensive approach to recovery. In this episode, she shares how technology in the investigative research field has evolved and why the noisiest cases are not always the ones you prioritize.Wendy Bailey is the Manager of Capital One's Threat Management Team where she assesses and manages workplace violence, intimate partner violence, and suicide concerns. Before transitioning to the private sector, she spent 19 years in Law Enforcement and held various roles including 14 years as a Detective. Key topics of Bailey's discussion with Dr. Marisa Randazzo include:How technology has evolved from landlines to social media and the speed of information available to investigate incidents.The importance of the initial interview for de-escalation, especially when the opportunity presents itself and the safety of the interviewer is ensured.The biggest challenges of her investigative work and how she manages a growing caseload and conducts long term monitoring.The benefit of diversity in experience for those wanting to enter the investigative field and the most important skill set needed.This episode focused on the importance of having an integrated system so teams can view a complete, accurate, and up-to-date picture of their threat landscape. Ontic's Integrated Research optimizes risk and threat management with identity, criminal activity, civil litigation, adverse media, and global public records coverage — all in one place. Reach out if you'd like to learn more. 

Rising Treasury Yields and uncertainty around the Fed's rate cut outlook dampened investor sentiment on Wednesday, extending the red run across the key indices for the week. The Dow Jones fell 0.2%, while the S&P500 and Nasdaq declined 0.5% and 0.6% respectively on Wednesday.Treasury yields have been rising over the last few sessions following key Federal Reserve member speeches that warned the easing of monetary policy may come slower than investors first expected. This prompted investors to flee equities in favour of bonds as a safer return on investment in the current market environment.Stronger than expected retail sales out of the US boosted some retail stocks on Wednesday indicating consumers are still spending despite the high interest rate and tough cost-of-living environment in the US. Retail sales in the world's largest economy rose 0.6% in December, a rise from 0.3% in November and above consensus expectations of a flat reading month-on-month.European markets closed the midweek session lower, extending on the global red run this week, as key inflation readings and World Economic Forum updates heightened investor concerns over the rate outlook in the region. The STOXX600 fell 1.1% as all sectors ended the day in the red led by mining stocks tumbling over 2.1%. Germany's DAX closed 0.84% lower, the French CAC lost 1.07% and, in the UK, the FTSE100 fell 1.5% on Wednesday after inflation in the UK rose unexpectedly to 4% year-on-year in December's reading.Locally on Wednesday, the Aussie market extended its red run into the midweek session, partly weighed on by global markets overnight on Tuesday, weak economic data out of China also weighed on the local market, and energy and materials stocks dragged the ASX lower on Wednesday. The energy sector sell-off was driven by the sliding price of oil yesterday amid escalating tensions in the Red Sea, however, we have seen a recovery in the price of oil this morning as a strong USD counteracts the Red Sea threat on the commodity.What to watch today:Ahead of Thursday's trading session here in Australia the SPI futures are expecting the ASX to open 0.27% lower, extended on the negative global run this week. The pullback in global equities this year so far wasn't unexpected as we saw markets both at home and overseas hover near all-time highs to end 2023. The pullback is primarily due to central banks around the world pushing back rate cut timeframes which is prompting investors to reposition in safer returns and diversified exposure through bonds and equities that perform better in the higher interest rate environment.On the commodities front this morning, oil is trading 0.6% higher at US$72.84/barrel, gold is down 1.06% at US$2006.10/ounce and iron ore is down 0.38% at US$130.50/tonne.AU$1.00 is buying US$0.65, 97.02 Japanese Yen, 52.14 British Pence and NZ$1.07.Trading Ideas:Bell Potter has maintained a buy rating on Integrated Research (ASX:IRI) and have slightly upgraded the price target on the leading global provider of experience management solutions from $0.60 to $0.66 following the company releasing a first half trading update including the company's statutory revenue and EBITDA expectations coming in above Bell Potter expectations and the maintenance of no debt and a strong cash balance by the company throughout the first half.And Trading Central has identified a bullish signal on Eagers Automotive (ASX:APE) following the formation of a pattern over a period of 88-days which is roughly the same amount time the share price may rise from the close of $14.37 to the range of $16.60 to $17.10 according to standard principles of technical analysis.

Results of the recent EMBARK study show that both enzalutamide plus leuprolide and enzalutamide monotherapy significantly improved metastasis-free survival compared with leuprolide alone in patients with prostate cancer who have high-risk biochemical recurrence. Lead author Stephen Freedland, MD, associate director for education and training and director of the Center for Integrated Research in Cancer and Lifestyle at Cedars-Sinai Cancer Center in Los Angeles, speaks with Robert A. Figlin, MD, the Steven Spielberg Family Chair in Hematology-Oncology at Cedars-Sinai, about how these findings should be applied in practice. Although the data represent a significant advance, Dr. Freedland suggests even more progress ahead, asking "This is the new standard, but for those [who] are really high-risk, how can we do even better?”

In honor of the Great American Smokeout, Oncology Data Advisor sat down with Stephen Freedland, MD, the Director of the Center for Integrated Research in Cancer and Lifestyle at Cedars-Sinai Medical Center, to discuss the impact that smoking has on prostate cancer, as well as to help raise awareness around smoking and share resources for those who are trying to quit.

If the market isn't scary enough, Andrew, Matt, and Claude in this Halloween special chat some spooky stock situations. As well as discussing 8Common, director loans, founder-led companies, Alcidion, Integrated Research and Iress, and retail businesses including Adore Beauty, Adairs, JB Hi-Fi, Nick Scali and Kogan.Follow us on Twitter: @BabyGiantsPodSubscribe to our channel: https://www.youtube.com/channel/UCSXgHHJ4XjWK-r1k4O0pj1g-----0:53 - Good News1:44 - 8Common (ASX: 8CO)5:24 - Director Loans7:26 - Founder-led companies14:49 - Pointerra (ASX: 3DP)16:17 - Alcidion Group (ASX: ALC)16:58 - Integrated Research (ASX: IRI) & Iress (ASX: IRE)21:25 - Spooky stock situations28:27 - Yellow Brick Road Holdings (ASX: YBR)31:56 - Vmoto (ASX: VMT) & Rectifier Technologies (ASX: RFT)33:11 - Adore Beauty Group (ASX: ABY)37:17 - Retailers39:35 - Adairs (ASX: ADH)40:32 - JB Hi-Fi (ASX: JBH) & Nick Scali (ASX: NCK)43:53 - Amazon & Kogan.com (ASX: KGN)

Get ready to dive into the inspiring journey of James Brennan, CEO of Linius (ASX:LNU).  Known for his analytical prowess and process-driven approach, James has led software and SaaS product development for both established corporations and startups, consistently achieving success. His extensive background in product management, sales, marketing and finance showcases his ability to grow businesses, uncover latent potential, and foster exceptional teams and cultures.Currently serving as the CEO of Linius Technologies, James is at the forefront of unlocking the value of global video content. Linius introduces a groundbreaking way to personalize and curate video experiences, empowering users to create personalized compilations seamlessly. Under James' leadership, Linius has achieved unprecedented financial milestones, secured major partnerships, and launched scalable SaaS offerings.James' influence goes beyond Linius, having led transformative growth phases at Integrated Research, Kaltura, BlueJeans Network and Polycom. Notably, he has orchestrated the launch of innovative SaaS solutions, expanded into new markets, and turned stagnating ventures into thriving market leaders. With a global perspective spanning Asia, North America and Europe, James is a master of SaaS business transformation, harnessing data-driven insights to reshape products, pricing, revenue models, and sales strategies.Join us for this episode as we delve into James' remarkable career journey and gain valuable insights from his strategic expertise that continues to shape the technology landscape.

“It's very easy to sit and read a recipe but the key is not going on a diet— you really need to adjust your way of life." —Stephen Freedland M.D. Eating healthy is not just about looking good, it is also about feeling good. Food has been used as medicine for centuries, and with the right knowledge and eating habits, we can use food to heal ourselves.  This week, Dr. Stephen Freedland delivers compelling reasons we must rethink our eating habits and lifestyle. Dr. Freedland is a leader in the field of urology, with expertise in the diagnosis and treatment of benign prostatic hyperplasia (BPH) and prostate cancer. He has contributed significantly to cancer prevention and awareness through a patient-centered approach that focuses on understanding the whole person rather than just the disease.  Join in as Dr. Freedland outlines a decade worth of research on how carbohydrate affects tumor growth, the challenges of conducting a clinical trial, how a personalized lifestyle can make greater impact, how we can gain more control over our health journey, and what can help us make better choices not only for our health but for our future.    Meet Stephen: Stephen Freedland, MD, is the director of the Center for Integrated Research in Cancer and Lifestyle, co-director of the Cancer Genetics and Prevention Program, and associate director for Faculty Development at the Samuel Oschin Comprehensive Cancer Institute. He is a faculty physician in the Division of Urology at the Cedars-Sinai Department of Surgery. Freedland's clinical expertise focuses on urological diseases, particularly benign prostatic hyperplasia, and prostate cancer. His approach toward cancer prevention and awareness focuses on treating the whole patient, not just the disease, by combining traditional Western medicine with complementary holistic interventions. His research interests include urological diseases and the role of diet, lifestyle, and obesity in prostate cancer development and progression, as well as prostate cancer among racial groups and risk stratification for men with prostate cancer.    Freedland has published over 400 studies, and his research has appeared in the Journal of the American Medical Association, Journal of the National Cancer Institute, Journal of Clinical Oncology, Journal of Urology, Cancer Prevention Research, Cancer and BJUI, among others. Freedland is an active reviewer for more than 50 journals. He sits on the editorial board for Cancer Prevention Research, European Urology, International Journal of Urology, Nature Reviews Urology and BJUI, and serves as editor-in-chief for Prostate Cancer and Prostatic Diseases and as a consulting editor for European Urology. Freedland earned his MD from the University of California, Davis. He completed a residency in urology at UCLA and a fellowship in urological oncology at Johns Hopkins. Before joining Cedars-Sinai, he was at Duke University, where he specialized in surgical oncology and urologic oncology, and served as an associate professor in the Division of Urology. Twitter  LinkedIn   Connect with Cedar-Sinai Medical Center:  Website Facebook  Twitter Instagram LinkedIn  YouTube Connect with NextGen Purpose: Website Facebook Instagram  LinkedIn YouTube Episode Highlights: 01:00 The Link Between Food and Cancer 06:49 Carbohydrate and Tumor Growth 12:15 Measurable Outcomes 16:25 Personalizing Lifestyle 22:06 Be an Active Participant in Your Health Journey 30:33 Make Better Choices  

Today's guests are Deloitte's Michael Bondar and Natasha Buckley. Michael is a principal in Deloitte's Advisory Business and the US and global leader of Deloitte's Enterprise Trust Practice. Natasha is a senior manager at the Deloitte Centre for Integrated Research. Trust drives enterprise performance and mitigates risk. Trust elevates customer and brand loyalty, which can increase revenue. It enhances levels of workforce engagement, which can result in increased productivity and workforce retention. They talk about the old adage that you can only manage what you can measure and how Deloitte measures trust to help clients make strategic decisions. Natasha and Michael also talk about how specific operating areas like superior customer service delivering innovative solutions or protecting customer data significantly elevate trust in a brand leading to higher performance. We talk about digital engagement and digital transformation and why they are key drivers of trust. About A.I. and how it can help to validate information accuracy. How trust across different stakeholder groups can be maintained and the trust challenges that lay ahead.

On Drexel University Week:  Climate change will lead to numerous challenges. Franco Montalto, professor in the department of civil, architectural, and environmental engineering, looks into finding ways to mitigate problems through educational practices. Dr. Montalto is a civil engineer interested in the development of ecologically, economically, and socially sensible solutions to urban environmental problems, with […]

In this episode, we discuss prostate cancer prevention.  Prostate cancer is the most common cancer in men and the second most lethal cancer in men in the United States.  But is there a way to prevent it?  Can lifestyle factors like diet, exercise, sexual activity, and even stress impact the development and growth of prostate cancer?  In order to answer those questions, we spoke to Dr Stephen Freedland, Professor of Surgery and Urology at the Cedars Sinai Medical Center in Los Angeles.  At Cedars Sinai, Dr Freedland serves as the Warschaw Robertson Law Families Chair in Prostate Cancer, the Director of the Center for Integrated Research in Cancer and Lifestyle and Co-Director of the Cancer Genetics and Prevention Program. Dr.  Freedland has published over 400 medical studies and sits on the editorial boards of multiple medical journals.  He currently serves as editor-in-chief of the medical journal Prostate Cancer and Prostatic Diseases .  Dr. Freedland completed his undergraduate studies at UCLA and received his medical degree from UC Davis.  He then completed his Urology residency training at UCLA and a fellowship in urologic oncology at Johns Hopkins.  Before joining Cedars-Sinai, Dr Freedland served as an Associate Professor of Urology at Duke University .

Men and their loved ones often ask what can be done to decrease their risk of getting aggressive prostate cancer and improve their overall outcomes if they do end up getting prostate cancer.  In honor of September's Prostate Cancer Awareness Month, I'm happy to present you with one of our most popular episodes from the archives, which features Dr. Stephen Freedland, a prostate cancer expert, and focuses on the role that diet and lifestyle play in the development and progression of prostate cancer. He will bring you up to speed today with all you need to know. Stay tuned for more! Dr. Stephen Freedland is a true visionary on the role of lifestyle and diet in prostate cancer. He wears many different hats. He is the Director of the Center for Integrated Research in Cancer and Lifestyle, Associate Director of Cedars-Sinai Cancer for Education and Training, Professor in the Division of Urology at the Cedars-Sinai Medical Center in Los Angeles, and a staff physician at the Durham VA Medical Center.  His approach to cancer prevention and awareness focuses on treating the whole patient, not just the disease, by combining traditional western medicine with complementary holistic interventions. His research interests include the role of diet, lifestyle, and obesity in prostate cancer development and progression, prostate cancer amongst racial groups, and restratification for men with prostate cancer.  He has published over 600 studies. He sits on the editorial board for Cancer Prevention Research, European Urology, International Journal of Urology, and Nature Reviews Urology, among others. He also serves as Editor-in-Chief for Prostate Cancer and Prostatic Diseases. He completed his urology residency training at UCLA and a fellowship in urologic oncology at Johns Hopkins. Before joining Cedars-Sinai, he was at Duke University as an associate professor in the Division of Urology.  Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: The link between obesity and aggressive prostate cancer. Men could potentially reduce the risk of getting prostate cancer by losing weight. Dr. Freedland talks about whether there is a particular diet that works best for everyone with prostate cancer. The truth regarding the association between a high-fat diet and the risk of getting prostate cancer. Avoiding sugar is the only area where all diets concur. Dr. Freedland recommends following whole food diets. What we know at this point about links to sugar and prostate cancer. The biggest challenge that prostate cancer patients face with their diet. Dr.Freedland shares some tips and advice for sticking to a healthy diet. What Dr. Freedland recommends for his patients in terms of exercise and habits for a healthy prostate. Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link here, on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up for the wait-list for our bonus video content.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here.  

Many men and their loved ones want to know what they can do to reduce the risk of getting aggressive prostate cancer and improve their overall outcomes if they end up with prostate cancer.  Our guest for today's show, Dr. Stephen Freedland, is a prostate cancer expert and a leader in the field regarding the role of diet and lifestyle in the development and progression of prostate cancer.  Dr. Stephen Freedland is a true visionary when it comes to the role of lifestyle and diet in prostate cancer. He wears many different hats. He is the Director of the Center for Integrated Research in Cancer and Lifestyle, Associate Director of Cedars-Sinai Cancer for Education and Training, Professor in the Division of Urology at the Cedars-Sinai Medical Center in Los Angeles, and a staff physician at the Durham VA Medical Center.  His approach to cancer prevention and awareness focuses on treating the whole patient, not just the disease, by combining traditional western medicine with complementary holistic interventions. His research interests include the role of diet, lifestyle, and obesity in prostate cancer development and progression, prostate cancer amongst racial groups, and restratification for men with prostate cancer.  He has published over 600 studies. He sits on the editorial board for Cancer Prevention Research, European Urology, International Journal of Urology, and Nature Reviews Urology, among others. He also serves as Editor-in-Chief for Prostate Cancer and Prostatic Diseases. He completed his urology residency training at UCLA and a fellowship in urologic oncology at Johns Hopkins. Before joining Cedars-Sinai, he was at Duke University as an associate professor in the Division of Urology.  Be sure to stay tuned today as Dr. Freedland brings you up to speed with all you need to know about the role of diet and lifestyle in the development and progression of prostate cancer. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: Dr. Freedland talks about the link between obesity and aggressive prostate cancer. Dr. Freedland discusses the possibility of men reducing the risk of getting prostate cancer by losing weight. Dr. Freedland discusses whether there is a particular diet that works best for everyone concerning prostate cancer. Dr. Freedland looks at the truth regarding the association between a high-fat diet and the risk of getting prostate cancer. Avoiding sugar is the only area where all diets concur. Dr. Freedland recommends following whole food diets. Dr. Freedland talks about what we know at this point regarding links to sugar and prostate cancer. The biggest challenge that prostate cancer patients face with their diet. Dr.Freedland shares some tips and advice for sticking to a healthy diet. Dr. Freedland shares what he recommends for his patients in terms of exercise and habits for a healthy prostate. Links and resources:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link here, on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up for the wait-list for our bonus video content.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here.

Jennifer Byrne has spent her whole career in clinical trials, working on more than 8000 studies. So she knows a thing or two about the needs of pharma sponsors, clinical sites and patients. As founder and CEO of Javara, Jennifer is spearheading a new concept: the integrated research organization or IRO, a novel model for bringing clinical research into the healthcare ecosystem.

The futures are suggesting a lift of 1.2% or 67 points, but trading is expected to be thin given it's a public holiday in NSW, SA, ACT, QLD – so expect industrials and economic recovery stocks to be stronger, and tech stocks to follow Wall Street lower. It's also going to be one of the busiest weeks economically since the pandemic - with the Australian Federal Budget being handed down tomorrow night and the RBA meeting with rates expect to remain on hold, while Westpac has gone out in a limb expecting a cut of 0.1%. What to watch today?• Oil tracks steady, US$37, Gold holds at US$1,908.  • On the economic side: NAB confidence numbers are out along with services sector data.  Trading ideas:• Integrated Research (ASX:IRI) was upgraded as a Buy by Bell Potter, with a new $4.25 target, on the back of the company releasing new products and renewing licences. Bell Potter is forecasting EPS growth of 10%, 11% and 15%, over the next three years.• AFT Pharma (ASX:AFP) was rated a Hold by Bell Potter, with an increased $5.11 target after seeing a strong rise in sales in over-the-counter medicines associated with the protection of COVID-19 infections.• Keep an eye on Black Cat Syndicate (ASX:BC8) and Amaysim (ASX:AYS) – both showing bullish charting signals - according to Trading Central. 

The Aussie share market is eyeing a fall of 0.6% at the open following Wall Street's decline.  U.S. equities closed lower on Friday and saw their third straight weekly fall. On Wall Street, investors continued to sell out of the Tech sector and invest into the best performing sector this month, Materials.What to watch:This week, manufacturing numbers will be released in the U.S., UK, the Eurozone and Australia, while Central banks will be meeting in China and New Zealand, deciding the future of interest rates.Local trading ideas:Costa Group (ASX:CGC), Australia's largest horticultural company, was initiated as a Bell Potter buy with a $4.05 price target, implying 24% growth in a year from Friday's close of $3.27. Citi and UBS also have the stock as a buy.Uniti Group (ASX:UWL) was upgraded by Bell Potter with a $1.90 target, implying 29% growth in a year from Friday's close of $1.47.Structural Monitoring Systems (ASX:SMN), Integrated Research (ASX:IRI) and Tesoro Resources (ASX:TSO) are all giving off bullish charting signals according to Trading Central.

The Aussie share market is eyeing a 0.3% gain at the open with the focus on Victorian COVID-19 cases declining. The Aussie share market has gained 0.4% so far this week, this puts the market on pace to close higher for the first time in 6 weeks.U.S. equities had their second straight negative session overnight, while stocks managed to end above their lows on Thursday. U.S. weekly job claims rose by 860,000 more than the expected 850,000, but the silver lining is that it's the third week now unemployment numbers have been under 1 million.Local trading ideas:Centuria Industrial REIT (ASX:CIP), Integrated Research (ASX:IRI) and NZME (ASX:NZM) are giving off bullish signals according to Trading Central's charting.Immutep (ASX:IMM), an immunotherapy business fighting metastatic cancer, was initiated as a Bell Potter speculative buy with a $0.60 target, implying 179% price growth in a year.Beach Energy (ASX:BPT) has been called out a high risk buy by Citi with a $1.94 target as its generating a higher level of cash than its peers and selling higher amounts of gas. Citi estimates BPT will generate $1.1 billion in free cash flow, which is worth $0.30 a share.

Aussie shares are set for a flat start this week, following a mixed session on Wall Street last Friday, where the Nasdaq and S&P500 rose 0.3% each, while the Dow fell 0.2%.With NSW eyeing another lockdown and Victoria in the thick of theirs, attention this week will be turned to Federal economic stimulus. We know the government plans to increase its support to small and medium businesses, giving access to cheap and part-guaranteed loans of $1 million from 1 October, an increase from $250,000.What to watch this week:- The RBA Governor on Tuesday will give a speech, and you'd expect bond buying or quantitative easing to be brought up.- Thursday's economic statement - revealing record debt and huge deficit forecasts, driven by massive increases in spending, and falls in revenue. We'll also get details of the further economic stimulus.Trading ideas:- A.P. Eagers (ASX:APE) - UBS initiated coverage of the automotive retailer, giving it a buy rating and price target of $7.90. On Friday it closed 0.5% up at $6.19. APE is the largest dealership group in Australia (with over 11% of new car market share) offering new and used vehicles, servicing, spare parts and financing service.- Integrated Research (ASX:IRI) - Bell Potter has downgraded the software provider from a buy to a hold with a $4.25 target. On Friday it rose 4.4% to $4.00, and it's collectively gained about 20% this year. Bell Potter forecasts high single digit percentage growth in revenue and low double digit percentage growth in NPAT in both FY21 and FY22.- Service Stream (ASX:SSM) - Bell Potter also downgraded the engineering infrastructure company from a buy to a hold with a $2.05 target. On Friday it closed 1.3% lower at $1.86. Bell Potter expects there to be about 9% upside in the stock but then expects things could dampen due to operational pressures from COVID-19 restrictions.

Dr. Naomi Gerber serves as the Director of Research for the Department of Medicine at Inova Fairfax Hospital in Virginia and the Outcomes Program at the Beatty Center for Integrated Research. After graduating from Tufts University School of Medicine, Dr. Gerber completed two residencies in internal medicine and rehabilitation medicine and a fellowship in rheumatology. She served as the Chief of the Rehabilitation Medicine Department at the Clinical Center, National Institutes of Health in Bethesda, Maryland and was instrumental in helping to develop the sub-specialty of rehabilitative rheumatology. In 2006, Dr. Gerber joined the faculty of George Mason University in the Health Administration and Policy Department and is co-director of the Laboratory for the Study and Simulation of Human Movement.  Listeners to Part 1 of Dr. Gerber’s presentation will recall that she talked about fatigue in the context of proteomics, performance, and perception. In Part 2, she began by asking how do we separate central fatigue from depression? It is a difficult question and may be why the biosignatures are so important. From a clinical perspective, sad and despairing feelings, anhedonia, really is the hallmark of depression. It’s not the hallmark of central fatigue, which is a different pathway. Many important factors here originate in the liver. We need to be attentive to the way we measure the specifics of both peripheral and central fatigue. We have objective measures that are quantitative and we have self-reports. Both are needed, along with observer-recorded reports to obtain a full picture of what we mean by fatigue. A perfect fatigue instrument has not been found yet. She described the fatigue severity scale and indicated some of its deficiencies. She also described the kinds of procedures undertaken in her laboratory to obtain a fuller understanding of fatigue. She indicated who can be considered fatigued. It’s usually women, individuals who are less active, who are obese or overweight, who are smokers with more than moderate alcohol intake, often complaining of depressed symptomology, and they are anxious. In her view, metabolic issues are under appreciated by our specialty. 

Dr. Naomi Gerber serves as the Director of Research for the Department of Medicine at Inova Fairfax Hospital in Virginia and the Outcomes Program at the Beatty Center for Integrated Research. After graduating from Tufts University School of Medicine, Dr. Gerber completed two residencies in internal medicine and rehabilitation medicine and a fellowship in rheumatology. She served as the Chief of the Rehabilitation Medicine Department at the Clinical Center, National Institutes of Health in Bethesda, Maryland and was instrumental in helping to develop the sub-specialty of rehabilitative rheumatology. In 2006, Dr. Gerber joined the faculty of George Mason University in the Health Administration and Policy Department and is co-director of the Laboratory for the Study and Simulation of Human Movement.  In Part 1 of her presentation, Dr. Gerber’s aim is to decipher fatigue in the context of proteomics, performance, and perception. She wants to describe the construct that is beginning to be shaped to enable us to understand fatigue better and indicate how it is effectively measured both objectively and subjectively. She mentioned that the term biosignature is a more robust term than biomarker because it represents multiple domain measures to help us understand complex ideas, such as fatigue. When talking about fatigue, it is necessary for individuals to report what they are experiencing. Expectation plays a role in what a person is trying to accomplish. In order to treat fatigue effectively, it is necessary to know the parameters. Her presentation included the topics of cancer fatigue and liver fatigue, noting that if we do not study the liver better, an important concept in the rehabilitation world, we are not going to conquer this problem. She made a distinction between pathological and non-pathological (normal) fatigue and how to treat these conditions. She also discussed peripheral and central fatigue. There is confusion in the domain culture about these kinds of fatigue and an effort is underway to identify a biosignature that gives a mix of objective measures linked to perception. A portion of the tryptophan pathway is critical for understanding fatigue, both peripheral and central.

In this week's episode, I interrupt the normal scheduling to bring you a special episode on space and bushfires. It seems that despite the technological advances that space has brought, we are still at the whim of nature when it comes to natural disasters. Or are we? To help me answer this question, I tracked down the best expert I know to tell me about the ongoing bushfire situation in Australia, and how space enabled technologies can assist efforts to predict, manage, and assess the impact of bushfires. It just so happens that he is also my Uncle. Professor John Handmer is an Emeritus Professor with the RMIT School of Science, and has qualifications and experience in human geography, economics and law. Recently named Australia's top researcher in emergency management, he chairs the Scientific Committee of the Integrated Research on Disaster Risk (IRDR) Program of ISC (International Council of Science and the UNDRR), and is, or has recently been, on a number of Australian advisory bodies, which cover climate change adaptation, disaster risk and resilience, and most recently the National Vulnerability Profile project. John also ran the Bushfire CRC's communities research program and the post-Black Saturday human dimensions research. Information on how to donate to help the bushfire relief effort: https://www.rfs.nsw.gov.au/news-and-media/general-news/how-you-can-helpJoin the Space Junk Podcast community: www.patreon.com/thespacejunkpod Support this show http://supporter.acast.com/space-junk-podcast. Support this show http://supporter.acast.com/space-junk-podcast. See acast.com/privacy for privacy and opt-out information.

We welcome another North Carolina local as our guest on this episode of People Always, Patients Sometimes – Jennifer Byrne.  Jennifer is the founder and CEO of Javara Research and coined the term Integrated Research Organization or IRO.  Jennifer also founded Greater Gift, a 501(c)3 nonprofit that donates one vaccine or meal for every clinical trial participant.  The former CEO of PMG Research, Jennifer also serves as a trustee for the ACRP, an Advisory Board member of CISCRP, and an Advisor Chair for the Masters in Clinical Research Management with Wake Forest University. During our conversation, Jennifer spoke about the growing trend of patient centricity in clinical research trials.  This trend correlates with the evolving complexity of clinical trials, especially with respect to the patient’s involvement.  While patient centricity is a progressive step for clinical trials, another aspect in need of updating is physician involvement.  Jennifer founded Javara Research with the focus on “building and providing infrastructure and resources to independent physicians.”  To expand the pool of available research candidates, as well as physician investigators, the pharma industry needs to reach out to the smaller practices, the doctors and patients outside of the larger research organizations.  According to Jennifer, communicating with patients is the key.  How many people have never contemplated participating in some sort of clinical research trial simply because no one had ever asked? Javara Research provides clinical trial infrastructure services to biopharmaceutical companies and CROs.  Javara puts the focus on creating a new model for clinical trials by engaging patients and physicians alike to expand the access and accessibility of clinical research trials for all involved. Founded in 2010, Greater Gift donates vaccines and meals to children in need through partnerships with Gavi, the Vaccine Alliance, and Feeding America.  To date, Greater Gift has donated 115,000 vaccines, all thanks to the participation of patients. To hear the full conversation, tune in for this week’s episode of People Always, Patients Sometimes, hosted by Janet Kennedy.  

Andrew pitches Integrated Research (ASX:IRI), Claude makes the case for Xref (ASX:XF1), and we answer some questions from listeners. Email us at threewisemonkeyspodcast@gmail.com @sage_simian @mattjoass @claudedwalker www.strawman.com www.ethicalequities.com.au www.mattjoass.com

“Coming of age digitally: Learning, leadership, and legacy” is an annual report from Deloitte’s Center for Integrated Research & MIT Sloan Management Review gauging how “digitally mature” today’s organizations are. The study found that that “digitization is changing the very nature of work — which in turn can require new ways of leading.” To learn more about this report, becoming a digitally mature organization, and what leaders can do in light of these findings, we’re joined by Anh Phillips of Deloitte. To learn more, and for the complete show notes, visit blionline.org/blog. Resources: Connect with Anh on LinkedIn “Coming of age digitally: Learning, leadership, and legacy” Future-Proof is produced by Podcast Masters

This week on the pod Phaedon Stough was lucky enough to talk with Steve Killelea; accomplished entrepreneur, business magnate, one of Australia’s most prolific philanthropists and founder of a global think tank, the Institute for Economics and Peace.You may never have heard of Steve, he's one of those quiet over-achievers, who has spent most of his business life working under the radar, yet has successfully built two software companies which he founded and turned into highly successful global businesses, as well as being Australia's largest donor foreign aid.Steve founded Integrated Research Ltd (IR), an Australian publicly-listed company with a 25-year heritage of providing performance management and payments software for business-critical computing. Through Steve’s direction as CEO and now as Chairman, IR has built an impressive, world-class customer base to make it one of Australia’s leading software companies. IR listed on the ASX and it's current market cap is $664 million of which Steve retains about 40% of the company.Steve has always had a strong passion for sustainable development, and in 2000 established The Charitable Foundation (TCF), one of the largest private overseas aid organisations in Australia. It aims to provide life-changing interventions reaching as many people as possible with special emphasis on targeting the poorest of the poor. TCF has substantially impacted the lives of over 2.3 million people.In 2007 Steve founded the international think tank Institute for Economics and Peace (IEP), dedicated to building a greater understanding of the interconnection between business, peace and economics with particular emphasis on the economic benefits of peace. IEP’s ground-breaking research includes the Global Peace Index, the world’s leading measure of peacefulness. Steve’s founding of IEP was recognized as one of the 50 most impactful philanthropic gifts in Australia’s history.Steve currently serves on a number of influential Company Boards, Advisory Boards and President Councils. In 2010 he was honoured as Member of the Order of Australia for his service to the global peace movement.It really was a pleasure to speak with one Australia's great entrepreneurs and a man who's made it his life's work to make the world and better more peaceful place. We hope you're inspired by Steve's story as much as we were.

Brenna Sniderman, senior manager and subject matter specialist at Deloitte Services LP’s Center for Integrated Research, talks with Laura Zarrow about what she does, how she got there, and the surprising ways that she contributes to the future of work. Sniderman works with other thought leaders to deliver insights into the strategic and organizational implications of things like additive and advanced manufacturing, Industry 4.0, the Internet of Things, and advanced technologies. She focuses on cross-industry themes and trends, and provides expertise on the organizational impacts of new technologies. Aired April 19, 2017 See acast.com/privacy for privacy and opt-out information.

Nick is a corporate technology lawyer with Norton, Rose & Fulbright based in Sydney. This bio is from the firm's website. Click here to get to the site. He is deeply involved in the Australian technology sector as a lawyer, adviser, non-executive director, former Dotcom entrepreneur and investor. He has worked on over $3 Billion of TMT-related transactions since 2012. He recently wrote the best-selling book Digital Disruption in Australia – A Guide for Entrepreneurs, Investors & Corporates. Nick is the national leader of our Communications, Media & Technology Group. His group has won the Australian Technology Law Firm of the Year Award. His experience in the TMT field was gained from hands-on industry experience both with major law firms in Australia and Tokyo and also with organisations such as the ASX-listed Spike Networks Limited in Los Angeles where he was Chief Operating Officer during 1999-2001 and prior to that in a non-legal executive position with Warner Brothers in Los Angeles. He is widely recognised for his breadth of knowledge and understanding of all aspects of technology, media and telecommunications. He regularly advises on tech-related M&A, cloud, IT procurement, outsourcing, IT/IP issues, internet and telecommunications matters, media regulation, content and privacy. Nick is past President of the Australian Communications and Media Law Association. He is the only private practice lawyer on the Federal Government’s Consultative Working Group on Cyber Safety. He was appointed by the NSW Finance Minister to the government’s Procurement Advisory Board and is on the Committee for Sydney’s Financial Services Knowledge Hub. He is a Non-Executive Director on ASX-listed Integrated Research (market cap approx. $400M). He is a director of the Institute for Economics and Peace, a not for profit dedicated to researching the linkage between peace and prosperity globally. The Institute is ranked in the top 15 Most Impactful Think Tanks in the world (with revenues < $5M). He is a Governor of the American Chamber of Commerce. He was named as a “Recommended Lawyer” in both the Outsourcing category and the Technology, Media and Telecommunications category of the 2012-2016 PLC Which Lawyer publication. He was named as a “Leading TMT Lawyer” in the 2013-2016 Asia Pacific Legal 500 and was named one of Australia’s best lawyers in the 2012-2016 Best Lawyers publication. Nick writes columns on Technology Law for the Sydney Morning Herald, The Age & The Financial Review newspapers. Find his book "Digital Disruption in Australia" here.

Join our conversation with IR (fka Integrated Research) as we discuss the solid alignment and customer value of their Prognosis solution in complement to Avaya systems.

Research activity accounts for a significant percentage of university business. The University of Liverpool has developed IRIS to enable research activity to be administered and reported on all levels.